Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, March 8 '25)

Image
By G.M.

 


    Antiviral Res

  1. PADEY B, Droillard C, Duliere V, Fouret J, et al
    Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARS-CoV-2.
    Antiviral Res. 2025 Mar 4:106138. doi: 10.1016/j.antiviral.2025.106138.
    PubMed         Abstract available


    Clin Infect Dis

  2. BULLOCK A, Dalton AF, Stockwell MS, McLaren SH, et al
    Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023.
    Clin Infect Dis. 2025 Feb 26:ciaf026. doi: 10.1093.
    PubMed         Abstract available

  3. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  4. BI K, Bandekar SR, Bouchnita A, Fox SJ, et al
    Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024.
    Emerg Infect Dis. 2025;31:636-638.
    PubMed         Abstract available

  5. AGUILAR-BULTET L, Gomez-Sanz E, Garcia-Martin AB, Hug MA, et al
    Extended-Spectrum beta-Lactamase-Producing Enterobacterales in Municipal Wastewater Collections, Switzerland, 2019-2023.
    Emerg Infect Dis. 2025;31:574-578.
    PubMed         Abstract available

  6. LEBER AL, Embry T, Everhart K, Taveras J, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.
    Emerg Infect Dis. 2025;31:555-558.
    PubMed         Abstract available


    Graefes Arch Clin Exp Ophthalmol

  7. KEYE P, Evers C, Glaser T, Braun P, et al
    Impact of the COVID-19 pandemic on glaucoma surgery in German hospitals.
    Graefes Arch Clin Exp Ophthalmol. 2025 Mar 7. doi: 10.1007/s00417-025-06787.
    PubMed         Abstract available


    Int J Infect Dis

  8. CAMELO S, Dioh W, Teixeira JP, Busse LW, et al
    Modulation of the Renin-Angiotensin System against COVID-19: A path forward?
    Int J Infect Dis. 2025 Mar 4:107867. doi: 10.1016/j.ijid.2025.107867.
    PubMed         Abstract available

  9. AKHTAR M, Hashmi AH, Manzoor S
    The Synergistic Tapestry: unraveling the interplay of Parvovirus B19 with other viruses.
    Int J Infect Dis. 2025 Feb 28:107865. doi: 10.1016/j.ijid.2025.107865.
    PubMed         Abstract available


    J Med Virol

  10. HANSEN KS, Jorgensen SE, Comert C, Schiottz-Christensen B, et al
    Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID.
    J Med Virol. 2025;97:e70275.
    PubMed         Abstract available


  11. Correction to "Low Neutralization of SARS-CoV-2 Omicron BA5248, XBB15 and JN1 by Homologous Booster and Breakthrough Infection".
    J Med Virol. 2025;97:e70271.
    PubMed        

  12. ZONG Y, Kamoi K, Zhang J, Yang M, et al
    The Silent Epidemic: Unveiling Herpetic Uveitis in the Elderly.
    J Med Virol. 2025;97:e70286.
    PubMed         Abstract available


    J Travel Med

  13. SHIFERAW W, Dean JA, Mills D, Lau CL, et al
    Overseas- and locally-acquired sexually transmissible infections in Australia, 2017-2023.
    J Travel Med. 2025 Mar 5:taaf022. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  14. KARL V, Hofmann M, Thimme R
    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
    J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350.
    PubMed         Abstract available

  15. MA Z, Li Z, Li Y, Zhao X, et al
    Changes in the motifs in the D0 and SD2 domains of the S protein drive the evolution of virulence in enteric coronavirus porcine epidemic diarrhea virus.
    J Virol. 2025 Mar 4:e0209224. doi: 10.1128/jvi.02092.
    PubMed         Abstract available

  16. HU H, Zhang Y, Zheng H, Zhao X, et al
    Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
    J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323.
    PubMed         Abstract available


    JAMA

  17. STAR J, Han X, Smith RA, Schafer EJ, et al
    Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Mar 5:e250902. doi: 10.1001/jama.2025.0902.
    PubMed        


    Lancet Infect Dis

  18. ZHANG L, Kempf A, Nehlmeier I, Chen N, et al
    Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1.
    Lancet Infect Dis. 2025 Feb 26:S1473-3099(25)00113.
    PubMed        


    Life Sci

  19. DUERR GD, Hamiko M, Beer J, Nattermann J, et al
    The interplay between COVID-19 and heart disease: Unravelling a complex connection.
    Life Sci. 2025 Mar 3:123524. doi: 10.1016/j.lfs.2025.123524.
    PubMed         Abstract available


    Nature

  20. TRAN-KIEM C, Paredes MI, Perofsky AC, Frisbie LA, et al
    Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences.
    Nature. 2025 Mar 5. doi: 10.1038/s41586-025-08637.
    PubMed         Abstract available


    Science

  21. WEI X, Qian W, Narasimhan H, Chan T, et al
    Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae.
    Science. 2025;387:eadq2509.
    PubMed         Abstract available

  22. SARIOL A, Perlman S
    Lung inflammation drives Long Covid.
    Science. 2025;387:1039-1040.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  23. ZHENG YJ, Hou JY, Zhong J, Ye XW, et al
    [A case of COVID-19-associated pulmonary aspergillosis combined with COVID-19-associated pulmonary mucormycosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:267-271.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »